Interleukin (IL)-9 has recently been shown to play an important role in all
ergic disease because its expression is strongly associated with the degree
of airway responsiveness and the asthmatic-like phenotype, IL-9 is a pleio
tropic cytokine that is active on many cell types involved in the allergic
immune response, Mucus hypersecretion is a clinical feature of chronic airw
ay diseases; however, the mechanisms underlying the induction of mucin are
poorly understood. In this report, we show that IL-9 regulates the expressi
on of a subset of mucin genes in lung cells both in vivo and in vitro. In v
ivo, the constitutive expression of IL-9 in transgenic mice results in elev
ated MUC2 and MUC5AC gene expression in airway epithelial cells and periodi
c acid-Schiff-positive staining (reflecting mucous glycogenates). Similar r
esults were observed in C57BL/6J mice after IL-9 intratracheal instillation
. In contrast, instillation of the T helper 1-associated cytokine interfero
n gamma failed to induce mucin production, In vitro, our studies showed tha
t IL-9 also induces expression of MUC2 and MUC5AC in human primary lung cul
tures and in the human muccoepidermoid NCl-H292 cell line, indicating a dir
ect effect of IL-9 on inducing mucin expression in these cells. Altogether,
these results suggest that upregulation of mucin by IL-9 might contribute
to the pathogenesis of human inflammatory airway disorders, such as asthma.
These data extend the role of the biologic processes that IL-9 has on regu
lating the many clinical features of asthma and further supports the IL-9 p
athway as a key mediator of the asthmatic response.